Jump to ContentJump to Main Navigation

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Editorial Board Member: Darendeliler, Feyza / Gustafsson, Jan / Luo, Feihong / Mericq, Veronica / Lanes M. D., Roberto / Battelino, Tadej / Buyukgebiz, Atilla / Cassorla, Fernando / Chrousos, George P. / Cutfield, Wayne / Fideleff, Hugo L. / Hershkovitz, Eli / LaFranchi, Stephen H. / Mohn, Angelika / Root, Allen W. / Rosenfeld, Ron G. / Wabitsch, Martin / Werther, George / Zadik, Zvi

12 Issues per year


IMPACT FACTOR increased in 2014: 0.995

SCImago Journal Rank (SJR) 2014: 0.378
Source Normalized Impact per Paper (SNIP) 2014: 0.454
Impact per Publication (IPP) 2014: 0.880

VolumeIssuePage

Issues

Nesfatin-1 in newborns: relationship with endocrine and metabolic and anthropometric measures

Ya-Ying Cheng1 / Xiu-Mian Zhao2 / Bao-Ping Cai2 / Li-Na Ma2 / Jian-Ying Yin2 / 1, 3

1Internal Medicine Teaching and Research Room, Hebei Medical University, Shijiazhuang, Hebei, China

2Department of Pediatrics, Hebei General Hospital, Shijiazhuang, Hebei, China

3Department of Endocrinology, Hebei General Hospital, Heping Road 348, Shijiazhuang, Hebei, 050051, China

Corresponding author: Dr. Guang-Yao Song, Internal Medicine Teaching and Research Room, Hebei Medical University, Shijiazhuang, Hebei, 050017, China; and Department of Endocrinology, Hebei General Hospital, Heping Road 348, Shijiazhuang, Hebei, 050051, China, Phone: +311-85988556

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 25, Issue 7-8, Pages 727–732, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/jpem-2012-0095, July 2012

Publication History

Received:
2012-03-27
Accepted:
2012-06-03
Published Online:
2012-07-19

Abstract

Objective: To explore the relationship between nesfatin-1 and growth and development in newborns.

Methods: Blood samples for nesfatin-1, ghrelin, insulin-like growth factor-1 (IGF-1), insulin and glucose were obtained from preterm (n=53) and term infants (n=60), including appropriate for gestational age (AGA) (n=32) and small for gestational age (SGA) infants (n=28). The relationship between nesfatin-1 and other metabolic hormones or anthropometric parameters was evaluated.

Results: The concentrations of nesfatin-1, ghrelin and insulin and the homeostasis model assessment-insulin resistance index (HOMA-IR) were higher in SGA than AGA infants (p=0.0358, 0.0163, 0.0001 and 0.0051, respectively), but IGF-1 levels and homeostasis model assessment-insulin sensitivity index (HOMA-ISI) were lower (p=0.033 and 0.0001, respectively). Nesfatin-1 levels in SGA infants were higher on postnatal day 0 (PND0) than in AGA infants (p=0.0358) and lower on PND7 (p=0.0002) and PND28 (p=0.0488). A negative correlation showed between nesfatin-1 and oral calorie intake (r=–0.446; p=0.017) and HOMA-ISI (r=–0.398; p=0.036), and a positive correlation between nesfatin-1 and HOMA-IR (r=0.43; p=0.023) in SGA infants.

Conclusion: Nesfatin-1 is involved in the physiological regulation of intrauterine and postnatal growth and development in SGA infants.

Keywords: energy homeostasis; growth and development; nesfatin-1; newborn

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Peng Shen, Yingying Han, Bo Cai, and Yu Wang
Sleep and Breathing, 2015, Volume 19, Number 2, Page 515
[2]
A. Stengel, M. Mori, and Y. Taché
Obesity Reviews, 2013, Volume 14, Number 11, Page 859
[3]
Suleyman Aydin
Endocrine, 2013, Volume 44, Number 2, Page 312

Comments (0)

Please log in or register to comment.